MediBuddy notices a 67% upsurge in Covid-19 consultations
National, 13th June 2022: With over 1 billion vaccinated across the country, the covid-19 pandemic still threatens our society. Witnessing a great rise in covid cases, individuals are compelled to mask up, maintain social distance and observe covid appropriate protocol to curb the spread of this noxious virus.
MediBuddy, India’s largest digital healthcare platform, noticed an increase of 67% in its online Covid-related expert online doctor consultation. Mumbai, Kochi, NCR, Bengaluru followed by Chennai, Hyderabad and Dehradun are among the top cities to approach MediBuddy for their covid-related queries. Their RTPCR testing rates also shot up to 84%. Similarly, ‘At home covid-care’ including delivery of medicines to one’s doorstep and other such services, increased by 41%.
Although the figure of those infected with the virus is on the rise, it is safe to say that due to the effective vaccines majority of Indians are either asymptomatic or facing milder symptoms. Moreover, the hospitalization and death rates are relatively low as compared to the pre-vaccine times. It is recommended that individuals above 18 and those eligible should receive the precautionary booster dose at the earliest.
Commenting on the same, Satish Kannan, Co-founder and CEO, MediBuddy, said, “The sudden increase in COVID cases is a cause of concern. It is critical for everyone, especially those with children at home, to take booster shots & preliminary medications at home to boost immunity and take the required precautions to stay safe from this deadly virus. At MediBuddy, we are vigilant of the rise in cases and thereafter have scaled up the assistance to beneficiaries. As a healthcare platform, we encourage everyone to conduct self-diagnosis at home under the able guidance of the healthcare platform to eliminate stepping out of the home. This will help to negate any possible fatalities."
Amidst the second wave, MediBuddy introduced several initiatives such as Hospital Bed Availability Tracker, a 24x7 helpline number, and a Coronavirus Risk Assessment Tool to help tackle the surge of coronavirus. It has tied up with 350+ top hospitals across 130 cities such as Delhi, Chennai, Bengaluru, Indore, Jaipur, Lucknow, Noida, and Kochi to further strengthen the vaccine rollout across the country. MediBuddy has always been the leading choice of Indians for a happier and healthier future.
*This Press Release is published by VOH team.*
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?
The First Active Bone Conduction Implant (Bone Bridge - BCI-602) in India was do
UPSC recommends Rajeev Singh Raghuvanshi as next DCGI
Mankind Pharma invests in Actimed Therapeutics, a UK based clinical stage specia
Tata Capital Healthcare Fund infuses $ 10 mn in Mumbai Oncocare CentreView All